Haspa buys minority stake in MT Derm

The company founder, Jörn Kluge, will remain the majority shareholder and managing director.

Haspa BGM focuses on long-term equity investments in medium-sized companies with a turnover of around €10m or more in the consumer, healthcare, industrial, oil and gas sectors.

The GP will support the company's plans to develop growth potentials as market leader in the sector.

Company
Haspa BGM was founded in 1998 and is headquartered in Berlin. With its own brands such as Cheyenne and Amiea, the company is certified as a medical manufacturer and makes products for tattoos and permanent make-up. MT Derm makes its products in Germany and delivers to more than 40 countries worldwide. It has estimated annual revenues of $59m, according to Hoovers.

People
MT Derm – Jörn Kluge (managing director, founder).
Haspa BGM – Oliver Melzer (managing director); Sven Bode (investment manager).

Advisers
Vendor – Transfer Partners (corporate finance, financial due diligence).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• DACH
• Consumer
• Germany